earticle

논문검색

Original Article

중환자실 내 병원성 폐렴 치료를 위한 Piperacillin/Tazobactam의 용량에 따른 효과와 안전성 비교

원문정보

Comparison of Piperacillin/Tazobactam Dosing (13.5 g/day vs. 18 g/day) for the Treatment of Hospital-Acquired Pneumonia and Ventilator-associated Pneumonia in Intensive Care Unit

강정은, 이경아, 김재송, 김수현, 손은선

피인용수 : 0(자료제공 : 네이버학술정보)

초록

영어

Background: In July 2016, the Infectious diseases society of america and the american thoracic society (IDSA & ATS) published a guideline recommending piperacillin/tazobactam (Pip/Tazo) 18 g/day as the anti-pseudomonal dose for the treatment of pathogenic pneumonia. After the guideline was published, the Pip/Tazo dose used for the treatment of pathogenic pneumonia was changed from 13.5 g/day to 18 g/day in a superior general hospital intensive care unit (ICU). In this study, we analyzed the effectiveness and safety of the new dose. Methods: Adult patients aged ≥19 years who were diagnosed with pneumonia in ICU and who received Pip/ Tazo for 7 days or more from September 1, 2015 to May 31, 2017 were included in the study. The electronic medical record (EMR) was retrospectively analyzed. Results: At baseline, there was a significant difference between 44 patients treated with 13.5 g/day and 31 patients treated with 18 g/day of Pip/Tazo. The 18 g/day-treatment group comprised more elderly patients than the 13.5 g/ day-treatment group (p=0.028). The results of the treatment-effects analysis showed no significant difference between the two groups. In case of safety data, there were significant differences in two parameters related to blood count, namely hemoglobin (p=0.016) and platelet count (p=0.011). Conclusion: Based on the significant difference in baseline age, there is a possibility that high-dose Pip/Tazo showed improved therapeutic effect. However, when high-dose Pip/Tazo was used, the blood cell count was found to drop from the reference value more frequently. Therefore, blood cell count should be monitored carefully when high-dose Pip/Tazo is administered.

목차

ABSTRACT
연구 방법
자료수집
연구 결과
환자정보
치료 효과
안전성
고찰
결론
참고문헌

저자정보

  • 강정은 Jeung Yun Kang. 연세대학교의료원 세브란스병원 약무국
  • 이경아 Kyung A Lee. 연세대학교의료원 세브란스병원 약무국
  • 김재송 Jae Song Kim. 연세대학교의료원 세브란스병원 약무국
  • 김수현 Soo Hyun Kim. 연세대학교의료원 세브란스병원 약무국
  • 손은선 Eun Sun Son. 연세대학교의료원 세브란스병원 약무국

참고문헌

자료제공 : 네이버학술정보

    함께 이용한 논문

      ※ 기관로그인 시 무료 이용이 가능합니다.

      • 4,000원

      0개의 논문이 장바구니에 담겼습니다.